Severe myocarditis due to influenza A(H1N1)pdm09 viral infection in a young woman successfully treated with intravenous zanamivir: A case report

Maria Mazzitelli; Eugenio Garofalo; Andrea Bruni; Giorgio Settimo Barreca; Angela Quirino; Aida Giancotti; Francesca Serapide; Ciro Indolfi; Giovanni Matera; Paolo Navalesi; Enrico Maria Trecarichi; Carlo Torti; Federico Longhini; IMAGES (Integrated MAnaGEment of Sepsis) Group

doi:10.1002/ccr3.2499

Severe myocarditis due to influenza A(H1N1)pdm09 viral infection in a young woman successfully treated with intravenous zanamivir: A case report

Clin Case Rep. 2019 Oct 21;7(12):2336-2340. doi: 10.1002/ccr3.2499. eCollection 2019 Dec.

Collaborators

IMAGES (Integrated MAnaGEment of Sepsis) Group:
Cinzia Peronace, Vincenzo Pisani, Chiara Costa, Giuseppe Greco, Valentina La Gamba, Vincenzo Scaglione, Eugenio Biamonte, Vincenzo Brescia, Brunella De Leonardis, Abdalla Karim, Giuseppina Cimino, Paola La Torre, Antonio Gemelli, Francesco Antonio Tropea, Francesco Picicco, Luigia Gallo

Affiliations

¹ Department of Medical and Surgical Sciences, Infectious and Tropical Diseases Unit "Magna Graecia" University Catanzaro Italy.
² Department of Medical and Surgical Sciences Unit of Intensive Care, "Magna Graecia" University Catanzaro Italy.
³ Department of Health Sciences Unit of Clinical Microbiology "Magna Graecia" University Catanzaro Italy.
⁴ Department of Medical and Surgical Sciences Division of cardiology "Magna Graecia" University Catanzaro Italy.

Abstract

In patients with influenza-related myocarditis, prompt diagnosis and treatment are important. Intravenous zanamivir can be an alternative to oral oseltamivir, especially in severe cases and when drug intestinal malabsorption is suspected or proven.

Keywords: influenza A(H1N1)pdm09 virus; intravenous zanamivir; myocarditis.

Publication types

Case Reports